Generalized anxiety disorder
J DeMartini, G Patel, TL Fancher - Annals of internal medicine, 2019 - acpjournals.org
Generalized anxiety disorder (GAD) is a common and disabling illness that is often
underdiagnosed and undertreated. Patients with GAD are at increased risk for suicide as …
underdiagnosed and undertreated. Patients with GAD are at increased risk for suicide as …
Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis
Background Generalised anxiety disorder is a disease that can be associated with
substantial dysfunction. Pharmacological treatment is often the first choice for clinicians …
substantial dysfunction. Pharmacological treatment is often the first choice for clinicians …
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients …
The Canadian Network for Mood and Anxiety Treatments (CANMAT) previously published
treatment guidelines for bipolar disorder in 2005, along with international commentaries and …
treatment guidelines for bipolar disorder in 2005, along with international commentaries and …
Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of panic disorder, social anxiety disorder and generalised …
Objective: To provide practical clinical guidance for the treatment of adults with panic
disorder, social anxiety disorder and generalised anxiety disorder in Australia and New …
disorder, social anxiety disorder and generalised anxiety disorder in Australia and New …
Diagnosis and management of generalized anxiety disorder and panic disorder in adults
Generalized anxiety disorder (GAD) and panic disorder (PD) are among the most common
mental disorders in the United States, and they can negatively impact a patient's quality of …
mental disorders in the United States, and they can negatively impact a patient's quality of …
Optogenetic investigation of neural circuits underlying brain disease in animal models
Optogenetic tools have provided a new way to establish causal relationships between brain
activity and behaviour in health and disease. Although no animal model captures human …
activity and behaviour in health and disease. Although no animal model captures human …
Cannabidiol for treatment-resistant anxiety disorders in young people: an open-label trial
Background: Treatment resistance is a significant problem among young people
experiencing moderate-to-severe anxiety, affecting nearly half of all patients. This study …
experiencing moderate-to-severe anxiety, affecting nearly half of all patients. This study …
Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines …
This revision of the 2005 British Association for Psychopharmacology guidelines for the
evidence-based pharmacological treatment of anxiety disorders provides an update on key …
evidence-based pharmacological treatment of anxiety disorders provides an update on key …
Benzodiazepine harm: how can it be reduced?
M Lader - British journal of clinical pharmacology, 2014 - Wiley Online Library
The benzodiazepines (BZDs) are anxiolytics, hypnotics, anticonvulsants, muscle‐relaxants
and induce anaesthesia. Adverse effects comprise sedation subjectively and cognitive and …
and induce anaesthesia. Adverse effects comprise sedation subjectively and cognitive and …
Alpha2delta ligands, gabapentin, pregabalin and mirogabalin: a review of their clinical pharmacology and therapeutic use
EP Calandre, F Rico-Villademoros… - Expert review of …, 2016 - Taylor & Francis
Introduction: The first two alpha2delta ligands–gabapentin (GBP) and pregabalin (PGB)–
were initially synthesized as antiepileptics; however, they were later also found to be useful …
were initially synthesized as antiepileptics; however, they were later also found to be useful …